Ferring). Primary outcomes were PPH (blood loss > 1000 mL) and the requirement for secondary uterotonics.
Results: We studied 1467 patients who received carbetocin and 1020 who received Syntocinon. The incidence of PPH was 6.7% versus 7.4% for carbetocin and syntocinon respectively (OR 0.84, 95% CI 0.62-1.16). Lower rates of moderate blood loss (500-999 mL) were observed for carbetocin; 11.0% versus 16.2% (OR 0.63, Stillbirth is a devastating event with enduring psychosocial consequences for families. Parents who conceive a subsequent pregnancy face an increased risk of stillbirth and other adverse outcomes in these pregnancies, and many experience profound anxiety and fear during this time. Parents who are pregnant subsequent to stillbirth comprise a small but unique group that may benefit from specialised and individualised care both clinically and psychosocially. However, there is currently a paucity of evidence to guide clinical practice.
Methods: A Cochrane systematic review assessing the effects of different interventions or models of care prior to and during subsequent pregnancies following stillbirth on maternal, fetal, neonatal and family health outcomes, and health service utilisation. Types of participants will include parents who have experienced a stillbirth of 20 weeks' gestation or more, who are pregnant or considering attempting a subsequent pregnancy. Eligible studies will include randomised controlled trials of any single intervention, combination of interventions or tailored model of care/algorithm/ guideline/protocol for improving health outcomes in pregnancies following stillbirth, compared with no intervention, standard care, or another intervention.
Results: Primary outcomes will be: stillbirth; neonatal death; adverse perinatal outcome (composite); and adverse maternal psychological effects.
Conclusions: Despite the far-reaching impacts of stillbirth on subsequent pregnancies and beyond, there is a paucity of information on care prior to and during these pregnancies to improve health outcomes. This Cochrane systematic review aims to inform clinical practice guidance for care in pregnancies subsequent to stillbirth and has been identified as a priority review topic by consumers. Background: Apnoea and bradycardia in preterm infants have been shown to be related to poor neurodevelopmental outcomes. Commonly the magnitude and frequency of bradycardia are underestimated in the neonatal unit due to the clinical settings of cardio-respiratory monitors. We evaluated the frequency, severity and duration of bradycardia in preterm infants using the lowest averaging (2 s) available on a clinical oximeter, in comparison with bradycardia detected using ECG and whether cerebral oxygenation was affected by bradycardia severity.
COMPARISON OF ECG DETECTED AND OXIMETRY
Methods: Nineteen preterm infants (10 M/ 9 F) born between 25-33 weeks of gestation were studied for 2 hours longitudinally with a total of 80 studies being analysed. Electrocardiogram (ECG), oxygen saturation (SaO 2 ), and cerebral tissue oxygenation index (TOI, %), were recorded. Heart rate calculated from ECG was used to determine whether the bradycardia was mild (HR fall 60-80% of the baseline), moderate (<60% of baseline) or severe (<60 bpm).
Results: A total of 614 bradycardias were scored using ECG criteria, 355 were mild, 237 moderate and 22 severe, 13% of the bradycardias detected as mild and 5% as moderate by the ECG were missed by the oximeter, all severe bradycardias were recorded. TOI dropped by 7.5%, 13.0% and 16.2% during the mild, moderate and severe bradycardias respectively.
Conclusions: This study has shown that even on the most sensitive setting of the oximeter, a significant number of bradycardias are not recorded. As even mild events are associated with clinically significant falls in cerebral oxygenation these may have important clinical implications for developmental outcomes. 
EXPRESSION OF CARDIAC ADRENOCEPTORS IN THE

